WCLC 2025 - Posters & ePosters-P3.12.38 Updated Clinical Results From FURTHER: A Study of Firmonertinib in TKI-Naive, Advanced NSCLC With EGFR PACC Mutations

P3.12.38 Updated Clinical Results From FURTHER: A Study of Firmonertinib in TKI-Naive, Advanced NSCLC With EGFR PACC Mutations

Asset Subtitle

Xiuning Le

Meta Tag

Speaker Xiuning Le

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy